{"id":"https://openalex.org/W2602031807","doi":"https://doi.org/10.1200/jco.2017.35.4_suppl.387","title":"Treatment patterns of gastrointestinal neuroendocrine tumors (NET).","display_name":"Treatment patterns of gastrointestinal neuroendocrine tumors (NET).","publication_year":2017,"publication_date":"2017-02-01","ids":{"openalex":"https://openalex.org/W2602031807","doi":"https://doi.org/10.1200/jco.2017.35.4_suppl.387","mag":"2602031807"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.4_suppl.387","doi":"https://doi.org/10.1200/jco.2017.35.4_suppl.387","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.4_suppl.387","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017807808","display_name":"Michael Samuel Broder","orcid":"https://orcid.org/0000-0002-2049-5536","observed_orcids":["https://orcid.org/0000-0002-2049-5536"]},"institutions":[{"id":"https://openalex.org/I4210106158","display_name":"Partnership for Health Analytic Research","ror":"https://ror.org/01qh9gp70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106158"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael S. Broder","raw_affiliation_strings":["Partnership for Health Analytic Research, LLC, Beverly Hills, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Partnership for Health Analytic Research, LLC, Beverly Hills, CA;","institution_ids":["https://openalex.org/I4210106158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010044319","display_name":"Eunice Y Chang","orcid":"https://orcid.org/0000-0003-0177-6153","observed_orcids":["https://orcid.org/0000-0003-0177-6153"]},"institutions":[{"id":"https://openalex.org/I4210106158","display_name":"Partnership for Health Analytic Research","ror":"https://ror.org/01qh9gp70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106158"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eunice Chang","raw_affiliation_strings":["Partnership for Health Analytic Research, LLC, Beverly Hills, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Partnership for Health Analytic Research, LLC, Beverly Hills, CA;","institution_ids":["https://openalex.org/I4210106158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038383749","display_name":"Beilei Cai","orcid":"https://orcid.org/0000-0002-2762-3908","observed_orcids":["https://orcid.org/0000-0002-2762-3908"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beilei Cai","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056390133","display_name":"Maureen P. Neary","orcid":"https://orcid.org/0000-0002-8584-3677","observed_orcids":["https://orcid.org/0000-0002-8584-3677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maureen Neary","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017613713","display_name":"Elya Papoyan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106158","display_name":"Partnership for Health Analytic Research","ror":"https://ror.org/01qh9gp70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106158"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elya Papoyan","raw_affiliation_strings":["Partnership for Health Analytic Research, LLC, Beverly Hills, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Partnership for Health Analytic Research, LLC, Beverly Hills, CA;","institution_ids":["https://openalex.org/I4210106158"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029706633","display_name":"Al B. Benson","orcid":"https://orcid.org/0000-0001-5485-7227","observed_orcids":["https://orcid.org/0000-0001-5485-7227"]},"institutions":[{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Al Bowen Benson","raw_affiliation_strings":["Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I4390039227"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"4_suppl","first_page":"387","last_page":"387"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gastrointestinal-neuroendocrine-tumors","display_name":"gastrointestinal neuroendocrine tumors","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.9160000085830688},{"id":"https://openalex.org/keywords/somatostatin-analogs","display_name":"somatostatin analogues","score":0.9909999966621399},{"id":"https://openalex.org/keywords/conventional-chemotherapy","display_name":"cytotoxic chemotherapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.9950000047683716},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.9729999899864197},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.9179999828338623},{"id":"https://openalex.org/keywords/real-world-treatment","display_name":"real-world treatment","score":0.492000013589859},{"id":"https://openalex.org/keywords/nccn-guidelines","display_name":"NCCN guidelines","score":0.7049999833106995},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9214261770248413},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7063900232315063},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.6674116849899292},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6259937882423401},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5482911467552185},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5054788589477539},{"id":"https://openalex.org/C2993493390","wikidata":"https://www.wikidata.org/wiki/Q5453208","display_name":"First line","level":2,"score":0.41657736897468567},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32775700092315674}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.4_suppl.387","doi":"https://doi.org/10.1200/jco.2017.35.4_suppl.387","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.4_suppl.387","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2754068412","https://openalex.org/W2908277915","https://openalex.org/W2601069602","https://openalex.org/W2789522327","https://openalex.org/W2799568387","https://openalex.org/W2791812985","https://openalex.org/W2941246023","https://openalex.org/W3006668619","https://openalex.org/W2606068898","https://openalex.org/W2993951959"],"abstract_inverted_index":{"387":[0],"Background:":[1],"NET":[2,23,99,136],"comprise":[3],"a":[4,34],"broad":[5],"set":[6],"of":[7,49,127,166,185,194,244,258,282,301,335],"rare":[8],"tumors.":[9],"Almost":[10],"2/3":[11],"arise":[12],"in":[13],"the":[14,302],"gastrointestinal":[15],"(GI)":[16],"tract.":[17],"NCCN":[18],"guidelines":[19,30],"for":[20,37,97,173],"unresectable":[21],"GI":[22,50,98,135],"recommend":[24,33],"somatostatin":[25],"analogues":[26],"(SSA)":[27],"first,":[28],"however,":[29],"do":[31],"not":[32,216],"particular":[35],"sequence":[36],"remaining":[38],"therapies.":[39,157],"Our":[40],"objective":[41],"is":[42,295,299,307],"to":[43,60,114,309],"describe":[44],"real":[45],"world":[46],"treatment":[47,103,116,191,249,271,322,336],"patterns":[48,272,323,337],"NET.":[51],"Methods:":[52],"This":[53],"retrospective":[54],"study":[55],"combined":[56],"2":[57,94],"claims":[58,96],"databases":[59],"examine":[61],"newly":[62,120,133,175],"pharmacologically":[63,245],"treated":[64,134,176,246],"patients":[65,118,177,186,213,247,283],"using":[66,324],"tabular":[67],"and":[68,82,150,252,263,278],"graphical":[69,227],"techniques.":[70],"Treatments":[71],"included":[72],"SSA,":[73,179,219],"cytotoxic":[74],"chemotherapy":[75],"(CC),":[76],"targeted":[77],"therapy":[78,142,169,204,304],"(TT),":[79],"interferon":[80],"(IF)":[81],"combinations.":[83],"Patients":[84,122],"\u2265":[85,89,93],"18":[86],"years,":[87],"with":[88,143,205,218,250,254,256],"1":[90,261],"inpatient":[91],"or":[92,209,305],"outpatient":[95],"who":[100,214],"received":[101,155,221],"pharmacologic":[102],"from":[104],"7/1/09-6/30/14":[105],"were":[106,119,123,276],"identified.":[107],"A":[108],"6":[109,266],"month":[110],"clean":[111],"period":[112],"prior":[113],"first":[115,140,167,195,237,274,291],"ensured":[117],"treated.":[121],"followed":[124],"until":[125],"end":[126],"enrollment.":[128],"Results:":[129],"We":[130,269],"identified":[131],"2,258":[132],"patients.":[137],"59.6%":[138],"started":[139],"line":[141,168,196,201,238,275,292],"SSA":[144,206,222,251],"monotherapy,":[145],"33.3%":[146],"CC,":[147,181,255],"3.6%":[148],"TT,":[149],"0.5%":[151],"IF.":[152],"The":[153],"remainder":[154],"combination":[156,203],"Mean":[158,164],"follow":[159],"up":[160],"was":[161,170,202,231],"576":[162],"days.":[163],"duration":[165,257],"361":[171],"days":[172],"all":[174],"(449":[178],"215":[180],"267":[182],"TT).":[183],"58.9%":[184],"had":[187,284],"no":[188,232,285],"subsequent":[189,286],"pharmarcological":[190],"after":[192,236,273,289,313],"discontinuation":[193],"therapy.The":[197],"most":[198,220],"common":[199],"second":[200,224],"(i.e.,":[207],"CC":[208],"TT":[210],"added).":[211],"In":[212,226],"did":[215],"begin":[217],"as":[223],"line.":[225],"pattern":[228,234],"analysis,":[229],"there":[230,298],"clear":[233],"visible":[235],"therapy.":[239,293],"Conclusions:":[240],"More":[241],"than":[242,280],"1/2":[243,281],"began":[248],"1/3":[253],"use":[259],">":[260],"year":[262],"just":[264],"over":[265],"months,":[267],"respectively.":[268],"found":[270],"unclear,":[277],"more":[279],"pharmacological":[287,303],"treatments":[288,332],"discontinuing":[290],"It":[294],"unclear":[296],"whether":[297],"underutilization":[300],"this":[306],"due":[308],"stable":[310],"disease":[311],"status":[312],"alternative":[314],"non-pharmacological":[315],"treatment.":[316],"Future":[317],"studies":[318],"directed":[319],"at":[320],"understanding":[321],"patient":[325],"medical":[326],"records":[327],"are":[328],"warranted.":[329],"As":[330],"new":[331],"emerge,":[333],"reassessment":[334],"may":[338],"be":[339],"needed.":[340]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-04-07T00:00:00"}